Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
05/2010
05/11/2010US7713534 Streptococcus pneumoniae proteins and nucleic acid molecules
05/11/2010US7713529 Methods for treating and preventing infectious disease
05/11/2010US7713522 using gutless adenovirus vector; gene therapy; gutless means incapable of expressing any adenovirus antigens; atherosclerosis
05/11/2010CA2366231C One step sample preparation and detection of nucleic acids in complex biological samples
05/11/2010CA2180965C Influenza vaccine
05/11/2010CA2165401C Immunogenic hybrid protein oprf-oprl derived from pseudomonas aeruginosa membrane proteins
05/11/2010CA2165297C Myeloid cell leukemia associated gene mcl-1
05/11/2010CA2122365C Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
05/10/2010CA2780482A1 Hdl particles for delivery of nucleic acids
05/06/2010WO2010051274A2 Fibronectin type iii domain based scaffold compositions, methods and uses
05/06/2010WO2010050939A1 Improved hcv vaccines and methods for using the same
05/06/2010WO2010048691A1 Multiplex genotyping assay for detecting mutations in k-ras
05/06/2010WO2010030396A3 Novel shrna gene therapy for treatment of ischemic heart disease
05/06/2010WO2010021702A9 Self-avoiding molecular recognition systems in dna amplification
05/06/2010WO2010017131A3 Modulation of toll-like receptor 7 expression by antisense oligonucleotides
05/06/2010WO2009138614A3 Novel method for preparing oligonucleotides comprising a 5’-phosphate monoester or 5’-thiophosphate monoester end
05/06/2010US20100115668 Ocp3 gene of arabidopsis thaliana and the ocp3 recessive mutation thereof, and the use of same as a resistance regulator in plants with disease caused by necrotrophic fungal pathogens
05/06/2010US20100115667 Novel At1g67330 gene involved in altered nitrate uptake efficiency
05/06/2010US20100115662 Manipulation of glutamine synthetases (gs) to improve nitrogen use efficiency and grain yield in higher plants
05/06/2010US20100115660 Compositions and Methods Using RNA Interference of OPR3-Like Gene For Control of Nematodes
05/06/2010US20100115659 Differential expression of subgenome specific alleles in cotton and uses thereof
05/06/2010US20100115658 Disease Resistant Plants
05/06/2010US20100115650 Herbicide-Resistant Brassica Plants and Methods of Use
05/06/2010US20100115639 Antibodies inhibiting c-met dimerization and uses thereof
05/06/2010US20100114956 System and method for inferring str allelic genotype from snps
05/06/2010US20100113811 Delta-15 desaturases genes suitable for increasing levels of omega-3 fatty acids
05/06/2010US20100113761 siRNA targeting beta secretase (BACE)
05/06/2010US20100113760 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing
05/06/2010US20100113759 Propargyl substituted nucleoside compounds and methods
05/06/2010US20100113758 Method for purifying biomolecules
05/06/2010US20100113755 Isolated modified human chorionic gonadotropin proteins
05/06/2010US20100113695 High capacity non-viral vectors
05/06/2010US20100113582 Methods and compositions for treating hiv infections
05/06/2010US20100113573 Modulation of hif1 beta expression
05/06/2010US20100113572 Photoreactive ru (ii) complexes anchored on oligonucleotides, method for obtaining them and use thereof
05/06/2010US20100113571 Compounds having anti-adhesive effects on cancer cells
05/06/2010US20100113569 Isolated dna fragment of the human a33 promoter and its use to control the expression of a heterologous gene in tumor cells
05/06/2010US20100113566 Nucleic acid for treatment or prevention of immunodeficiency virus infection
05/06/2010US20100113564 Chemically synthesized nucleic acid molecule; nucleic acids with a pyrimidine modification; inflammatory, respiratory, pulmonary, autoimmune, cardiovascular, neurodegenerative, and/or proliferative and cancerous diseases, traits, or conditions
05/06/2010US20100113562 Therapeutic targets and molecules
05/06/2010US20100113561 Microrna molecules
05/06/2010US20100113560 Compositions and methods for treating hematopoietic malignancies
05/06/2010US20100113558 Compounds and methods
05/06/2010US20100113557 Method for prevention of tumor
05/06/2010US20100113470 Bcr-abl variants
05/06/2010US20100113361 Anti-ige vaccines
05/06/2010US20100113356 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
05/06/2010US20100113355 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
05/06/2010US20100113354 Therapeutic agent comprising vasohibin
05/06/2010US20100113351 Therapeuting Compositions Comprising an RNAi Agent and a Neurotrophic Factor and Methods of Use Thereof
05/06/2010US20100113343 Methods involving lef-1 regulation and use of lef-1 or compounds altering lef-1 signalling for treating or preventing diseases
05/06/2010US20100113340 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
05/06/2010US20100113339 Serum albumin binding proteins with long half-lives
05/06/2010US20100113332 Method of treating an inflammatory disease by double stranded ribonucleic acid
05/06/2010US20100113307 siRNA targeting vascular endothelial growth factor (VEGF)
05/06/2010US20100113306 siRNA Targeting connective tissue growth factor (CTGF)
05/06/2010US20100113303 Polypeptide Display Libraries and Methods of Making and Using Thereof
05/06/2010US20100113292 Methods of obtaining active antisense compounds
05/06/2010US20100113284 Small interfering rna (sirna) target site blocking oligos and uses thereof
05/06/2010US20100112714 Biochip
05/06/2010US20100112711 Method of detecting amplification or deletion in genomic dna fragment
05/06/2010US20100112705 Polynucleotides for use as tags and tag complements, manufacture and use thereof
05/06/2010US20100112701 Reductase, gene thereof and method of using the same
05/06/2010US20100112688 Screening Methods for Compounds that Modulate the Activity of G-Protein Coupled Receptors
05/06/2010US20100112687 Nucleic acid compounds for inhibiting erbb family gene expression and uses thereof
05/06/2010US20100112686 Short hairpin rnas for inhibition of gene expression
05/06/2010US20100112685 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities
05/06/2010US20100112671 Host Cells for Production of Isoprenoid Compounds
05/06/2010US20100112666 Dehalogenases, Nucleic Acids Encoding Them and Methods for Making and Using Them
05/06/2010US20100112657 Nucleic acids and constructs for increasing galactose catabolism and methods therefor
05/06/2010US20100112651 Nucleotide sequences that encode enzymes that change carbon flux through metabolic pathways that lead to lactic acid or fumarate production in a host cell, such as a R. oryzae cell
05/06/2010US20100112648 (r)-hydroxynitrile lyase from brassicaceae
05/06/2010US20100112643 Method for direct capture of ribonucleic acid
05/06/2010US20100112637 Polypeptides Having Alpha-Amylase Activity and Polynucleotides Encoding Same
05/06/2010US20100112616 NOVEL BETA-GALACTOSIDE-a2,6-SIALYLTRANSFERASE, A GENE ENCODING THEREOF, AND A METHOD FOR ENHANCING ENZYME ACTIVITY
05/06/2010US20100112602 Protein-Protein Interaction Biosensors and Methods of Use Thereof
05/06/2010US20100112591 Tumor Suppressor Gene
05/06/2010US20100112587 Transcriptomic biomarkers for individual risk assessment in new onset heart failure
05/06/2010US20100112585 Method for Enriching Methylated CpG Sequences
05/06/2010US20100112582 Gene encoding labyrinthin, a marker for cancer
05/06/2010US20100112574 Method for the Simultaneous Determination of Blood Group and Platelet Antigen Genotypes
05/06/2010US20100112571 Compositions and methods for detecting mutations in jak2 nucleic acid
05/06/2010US20100112562 Mutation Implicated in Abnormality of Cardiac Sodium Channel Function
05/06/2010US20100112559 Primer set for amplifying obesity gene, reagent for amplifying obesity gene containing the same, and the uses thereof
05/06/2010US20100112554 Nucleic acid ligands to complex targets
05/06/2010US20100112553 Luciferase gene optimized for use in imaging of intracellular luminescence
05/06/2010US20100112548 Kit for detecting non-pathogenic or pathogenic influenza a subtype h5 virus
05/06/2010US20100112546 Nanoscale sensors
05/06/2010US20100112080 MULTIMERIC Fc RECEPTOR POLYPEPTIDES INCLUDING A MODIFIED Fc DOMAIN
05/06/2010US20100112008 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
05/06/2010US20100111996 Papaya Mosaic Virus-Based Vaccines for Influenza
05/06/2010US20100111993 Recombinant vaccines and use thereof
05/06/2010US20100111990 Polypeptide Recognized by Anti HIV-1 GP41 Antibodies Isolated from Highly HIV-1 Exposed, Non Infected Women
05/06/2010US20100111989 Rsv f-protein and its use
05/06/2010US20100111988 Small peptide for anti-angiogenesis and use thereof
05/06/2010US20100111974 Treatment of Cachexia
05/06/2010US20100111966 Engineered anti-il-23p19 antibodies
05/06/2010US20100111959 Engineered anti-il-13 antibodies, compositions, methods and uses
05/06/2010US20100111958 Notch-Binding Agents and Antagonists and Methods of Use Thereof
05/06/2010US20100111953 Antibodies that immunospecifically bind to b lymphocyte stimulator
1 ... 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 ... 899